Current challenges in the clinical management of hypertension
- 25 October 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 9 (5) , 267-275
Abstract
Elevated blood pressure (BP) is probably the most-important modifiable risk factor for cardiovascular disease (CVD). BP influences the development of CVD, even if levels of BP are well below the usual cut-off point that defines the presence of arterial hypertension. Adequate measurement of BP is the most-important requirement for the diagnosis and treatment of patients with suspected hypertension. The use of methodologies such as ambulatory and home BP monitoring have become powerful tools for defining the 'real' BP of patients, discarding the white-coat effect, and discovering masked hypertension. Early intervention with life-style changes and antihypertensive drugs is required to obtain the best outcome for the patient. In this sense, early use of combination antihypertensive drug therapy is recommended. The treatment of resistant hypertension—the type of elevated BP that is most difficult to control—has clearly improved over the past decade. Further studies are required to define how antihypertensive therapy should be used in the earliest stages of hypertension and for the treatment of patients with a mild-to-moderate increase in global cardiovascular risk.Keywords
This publication has 86 references indexed in Scilit:
- Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular DiseaseJournal of the American Society of Nephrology, 2011
- Effects of the Angiotensin Receptor Blocker Azilsartan Medoxomil Versus Olmesartan and Valsartan on Ambulatory and Clinic Blood Pressure in Patients With Stages 1 and 2 HypertensionHypertension, 2011
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery DiseaseJAMA, 2010
- Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and HyperaldosteronismHypertension, 2010
- Discrepancies between Office and Ambulatory Blood Pressure: Clinical ImplicationsThe American Journal of Medicine, 2009
- Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant HypertensionHypertension, 2009
- Lowering Blood Pressure Reduces Renal Events in Type 2 DiabetesJournal of the American Society of Nephrology, 2009
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 DiabetesDiabetes Care, 2008